Skip to main content
. 2018 May 15;32(4):1436–1441. doi: 10.1111/jvim.15145

Table 2.

Hematologic parameters—groups are defined as PCR‐positive nasal swab/respiratory disease clinical signs positive (PCR+/CS+), PCR‐negative nasal swab/respiratory disease clinical signs positive (PCR–/CS+), PCR‐positive nasal swab/respiratory disease clinical signs negative (PCR+/CS–), and PCR‐negative nasal swab/respiratory disease clinical signs negative (PCR–/CS–)

Parameter Mean (SD) PCR+/CS+ (n = 31) PCR–/CS+ (n = 56) PCR+/CS– (n = 19) PCR–/CS– (n = 26) One‐way ANOVA
Hematocrit (%) 35.2 (4.2) 35.8 (4.3) 37.8 (2.7) 35.2 (4.0) P = .11
White blood cells/μL 8598 (2100) 7901 (1984) 8021 (1557) 8275 (1489) P = .39
Neutrophils/μL 5204 (1334) 5107 (1317) 5271 (1325) 5246 (1208) P = .95
Lymphocytes/μL 2929 (1466) 2364 (961) 2378 (719) 2605 (766) P = .092
Monocytes/μL 340 (210) 295 (109) 252 (112) 296 (107) P = .18
Fibrinogen (mg/dL) 281 (120) 267 (102) 258 (84) 269 (84) P = .80